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Abstract
Background: To investigate the influence of cardiovascular magnetic resonance (CMR) timing after reperfusion on
CMR-derived parameters of ischemia/reperfusion (I/R) injury in patients with ST-segment elevation myocardial
infarction (STEMI).
Methods: The study included 163 reperfused STEMI patients undergoing CMR during the index hospitalization. Patients
were divided according to the time between revascularization and CMR (Trevasc-CMR: Tertile-1≤ 43; 43 < Tertile-2≤ 93;
Tertile-3 > 93 h). T2-mapping derived area-at-risk (AAR) and intramyocardial-hemorrhage (IMH), and late gadolinium
enhancement (LGE)-derived infarct size (IS) and microvascular obstruction (MVO) were quantified. T1-mapping was
performed before and > 15 min after Gd-based contrast-agent administration yielding extracellular volume (ECV) of
infarct.
Results: Main factors influencing I/R injury were homogenously balanced across Trevasc-CMR tertiles. T2 values of infarct and
remote regions increased with increasing Trevasc-CMR tertiles (infarct: 60.0 ± 4.9 vs 63.5 ± 5.6 vs 64.8 ± 7.5 ms; P < 0.001;
remote: 44.3 ± 2.8 vs 46.1 ± 2.8 vs ± 46.1 ± 3.0; P = 0.001). However, T2 value of infarct largely and significantly exceeded
that of remote myocardium in each tertile yielding comparable T2-mapping-derived AAR extent throughout Trevasc-CMR
tertiles (17 ± 9% vs 19 ± 9% vs 18 ± 8% of LV, respectively, P = 0.385). Similarly, T2-mapping-based IMH detection and
quantification were independent of Trevasc-CMR. LGE-derived IS and MVO were not influenced by Trevasc-CMR (IS: 12 ± 9% vs
12 ± 9% vs 14 ± 9% of LV, respectively, P = 0.646). In 68 patients without MVO, T1-mapping based ECV of infarct region
was comparable across Trevasc-CMR tertiles (P = 0.470).
Conclusion: In STEMI patients, T2 values of infarct and remote myocardium increase with increasing CMR time after
revascularization. However, these changes do not give rise to substantial variation of T2-mapping-derived AAR size nor of
other CMR-based parameters of I/R.
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Background
Cardioprotection after primary percutaneous coronary
intervention (PPCI) involves therapy which reduced
myocardial damage due to ischemia/reperfusion (I/R),
with the aim of minimizing infarct size in patients
with ST-segment elevation myocardial infarction
(STEMI) [1]. This field is rapidly expanding and relies
heavily on non-invasive imaging-based quantitative
metrics of ischemic myocardial damage. In this sense,
cardiovascular magnetic resonance (CMR) plays a
crucial role given its ability to non-invasively depict
and quantify the diverse components of ischemic
damage with high precision and reproducibility [2].
Accordingly, several CMR-based parameters of I/R
have been adopted as surrogate end-points in several
cardioprotective studies, obviating costly and ethically
questionable large clinical trials [2, 3]. Early after
STEMI, CMR allows to measure IS, infarct-related
myocardial edema, an estimate of area-at risk (AAR),
as well as intramyocardial hemorrhage (IMH) and
microvascular obstruction (MVO), two markers of
microvasculature damage [2, 4]. However, recent
studies have cast doubts about the reliability of these
parameters when CMR is carried out early after
reperfusion [5–12]. In particular, they underpinned
that infarct-related myocardial edema features a highly
dynamic course after reperfusion rising concerns
about the optimal timing of CMR. However, these
studies were limited by small and selective study pop-
ulations, and the time course of edema was rather
heterogeneous as compared to pivotal experimental
studies conducted in well-controlled I/R animal
models [6–9]. Indeed, in STEMI patients the pattern
of infarct-related edema may be influenced by dispar-
ate poorly quantifiable factors, including the severity
and duration of ischemia as well as spontaneous
cardioprotection phenomena [9, 13]. Most important,
the above studies relied largely on T2-weighted CMR
for AAR quantification, which is less accurate, precise
and robust than novel mapping techniques for edema
quantification [14, 15].
Based on these premises, we studied a cohort of
consecutive unselected reperfused STEMI patients
using comprehensive CMR including mapping tech-
niques during the index hospitalization to assess
whether and to which extent the dynamics of edema
influence CMR-derived parameters of I/R damage.
Methods
Study population
This is a pre-specified study originating from a single-
center registry which prospectively included STEMI pa-
tients undergoing CMR during the index hospitalization.
Between July 2014 and June 2017, 195 patients with the
diagnosis of STEMI were assessed for study inclusion at
Lausanne University Hospital. Patients were included if
they were older than 18 years, met the electrocardio-
gram (ECG) criteria for STEMI and were treated by
PPCI. Exclusion criteria included refractory cardiogenic
shock, prior myocardial infarction or coronary revascu-
larization, claustrophobia, and glomerular filtration rate
< 30 mL/min/1.73m2. The study was approved by insti-
tutional review board and all patients provided written
informed consent.
Cardiovascular magnetic resonance protocol
All patients underwent CMR at 1.5 Tesla (Siemens
Healthineers, Aera-Magneton, Erlangen-Germany). All
studies were performed using dedicated cardiac software,
32-channel phased-array surface receiver coil and ECG
triggering. Cine images were acquired using a breath-
hold balanced steady-state free-precession (bSSFP) in
long-axis and short-axis views. A stack of short-axis
slices was acquired to quantify left ventricular (LV) vol-
umes, mass and ejection-fraction. T2-mapping data were
acquired by breath-hold T2-prepared bSSFP in the same
orientation of short-axis cine images [14]. T2-maps were
readily evaluated by an experienced operator during
CMR scan, and a single short-axis target-slice was
selected in the middle of infarction (Supplemental-
Material). Native and post-contrast T1-mapping data
were acquired in the target-slice using ECG-triggered
breath-hold MOdified Look-Locker Inversion Recovery
(MOLLI) sequence with a 5(3)3 and 4(1)3(1)2 sampling
scheme for native and post-contrast T1-maps, respect-
ively [16]. Ten minutes after 0.2 mmol/Kg i.v. bolus of
Gadobutrol (Gadovist, Bayer Healthcare, Berlin,
Germany), late gadolinium enhancement (LGE) images
were acquired using a 2D breath-hold phase-sensitive
segmented inversion-recovery gradient echo in the same
orientations of cine images. Inversion-time was individu-
ally optimized to null normal myocardium. In the
target-slice, post-contrast T1-mapping was acquired at
the end of LGE imaging (> 15 min after Gadobutrol
bolus injection). Sequences and protocol are detailed in
the Supplemental-Material.
Image analysis
All studies were analyzed by a single operator with >
10 years experience in CMR (PGM) using GTVolume
software (GyroTools, Version 2.2.1, Zurich-Switzerland).
LV volumes, mass, and ejection-fraction were calculated
by manually delineating endocardial and epicardial
borders in the stack of short-axis cine images. For each
T2-map, endocardial and epicardial borders were
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manually traced. A region-of-interest was drawn in the
central-layer of the remote myocardium, and edema was
quantified as myocardium with T2 value≥2 standard-
deviation of remote myocardium (≥upper limit of the 95%
confidence-intervals of the mean T2 values of remote
myocardium) [17]. IMH was defined as myocardium
within edema showing T2 value< 2 standard-deviation of
mean T2 of the remote myocardium. Automatically-
defined contours of AAR were manually corrected by
adding or removing pixels which were incorrectly disre-
garded or excluded by the software, respectively. AAR and
IMH were quantified by summing edema and IMH mea-
sured in each slice, and expressed as absolute (grams) or %
of LV mass (% of LV). In hemorrhagic infarcts, IMH
was added to edema for AAR quantification. Mean
T2 values of AAR, IMH, and remote myocardium
were measured. Native and post-contrast T1 values of
the target-slice were measured in the infarct and re-
mote myocardium. Extracellular volume (ECV) in the
infarcted and remote regions was calculated by adop-
ting the validated equation (Supplemental Material).
On LGE images, infarct size was quantified as myo-
cardium with a signal intensity exceeding the mean
signal intensity of remote myocardium by >5SD [18].
MVO was defined as hypointense core embedded in
the hyperenhanced myocardium and, if present, was
included in hyper-enhanced myocardium for infarct
size quantification. Infarct size and MVO were ex-
pressed as absolute value (gram) or as percentage of
LV mass (% of LV). Myocardial salvage index is calcu-
lated as: [(AAR − IS)/AAR]x100.
Determination of the interval between revascularization
and CMR
The time (day and hour) of PPCI and CMR were re-
corded. First stent deployment in the infarcted-related
artery was considered as the time of reperfusion,
whereas beginning of CMR exam during the index
hospitalization was used as CMR time. Time between
reperfusion and CMR was calculated (TRevasc-CMR).
Statistical analysis
Continuous data were expressed as mean ± SD or as
median (25th–75th percentile), and categorical data as
frequency with percentage (%). Comparison of categorical
variables between groups was performed by χ2 test, or by
Fisher exact test if the expected cell count was < 5.
One-way ANOVA or nonparametric Kruskal-Wallis tests
were used as appropriate to compare continuous variables
between Trevasc-CMR tertiles. Bonferroni post-hoc was used
to test differences between two independent groups. All
tests were 2 tailed, and P < 0.05 was considered
statistically significant. Analyses were performed with
SSPS version 21 (International Business Machines, Inc.,
Armonk, New York, USA).
Results
Study population
Among the 195 patients evaluated for study eligibility, 9
patients did not undergo CMR because of claustropho-
bia or refusal of the exam. Twenty-three patients were
excluded after CMR because of time-to-reperfusion
exceeded 12 h from symptoms onset, previous myocar-
dial infarction / coronary revascularitation or insuf-
ficient LGE quality. One-hundred-sixty-three patients
were finally included (Fig. 1). Patients were then di-
vided according to Trevasc-CMR tertiles (Table 1).
Fifty-three (32%) patients showed pre-PPCI blood flow
in the ischemic myocardium at risk via the infarct-
related artery (TIMI-flow-grade ≥ 2; n = 42) or colla-
terals (Rentrop-grade ≥ 2; n = 11). Patients in Tertile-3
tended to be older presenting with lower systolic blood
pressure at hospital admission than patients in
Tertile-1 or Tertile-2. Except for these variables, base-
line characteristics were comparables across TRevasc-CMR
tertiles (Table 2).
Differences of AAR, infarct size and microvascular
damage and LV functional parameters according to the
time between revascularization and CMR
Results are summarized in the Table 2. AAR remained
stable across TRevasc-CMR tertiles (Fig. 2). Overall 46
(28%) patients showed IMH on T2-mapping. Occur-
rence and extent of IMH did not differ among
TRevasc-CMR tertiles. IS and occurrence and extent of
MVO as well as myocardial salvage index were com-
parable throughout TRevasc-CMR tertiles (Fig. 2). LV
end-diastolic volume index increased slightly across
TRevasc-CMR tertiles, so that patients in Tertile-3
patients had larger volume than those in Tertile-1.
LV end-systolic volume index, regional and global
systolic function parameters were comparable across
TRevasc-CMR tertiles.
T2 relaxation times in infarct and remote regions
Overall T2 of infarct region was consistently higher
than that of remote region throughout TRevasc-CMR
tertiles, and as compared to normal values of our
center (48.5 ± 2.4 ms). Infarct T2 increased between
Tertile-1 and Tertile-2 without further increase
between Tertile-2 and Tertile-3. A small increase of
T2 relaxation time was also observed in the remote
myocardium across TRevasc-CMR tertiles (Fig. 3). When
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patients were divided according to presence or ab-
sence of IMH, only patients without IMH showed an
increase of infarct T2 values between Tertile-1 and
Tertile-2 (Fig. 4). Differently, patients with IMH pre-
sented a constant elevation of T2 values within the
infarct region throughout TRevasc-CMR tertiles. When
comparing T2 values between patients with and with-
out IMH, Tertile-1 patients with IMH tended to have
higher infarct T2 value than those without IMH (62.2
± 5.6 vs 59.4 ± 4.6 ms, P = 0.085) (further details in
Table 2; Supplemental Material). By dichotomizing
patients according to presence (n = 53, pre-PPCI
TIMI flow-grade or Rentrop flow-grade ≥ 2) or ab-
sence (n = 110; pre-PPCI TIMI flow-grade or Rentrop
flow-grades< 2) of residual blood blow in the ischemic
myocardium, both subgroups showed a significant
increase of T2 values with increasing TRevasc-CMR
tertiles in both the infarct and remote regions (Fig. 5).
By comparing patients with or without pre-PPCI
residual blood flow, Tertile-1 patients with residual
blood flow showed lower infarct T2 value than those
without (57.0 ± 3.6 vs 61.2 ± 4. ms, P = 0.003) (further
details in Table 3; Supplemental Material).
T1 relaxation time and extracellular volume fraction in
the infarct and remote regions
T1 values of infarct and remote regions were measured in
the target-slice of 124 patients. Overall, T1 of infarct was
higher than that of remote region throughout TRevasc-CMR
tertiles, and as compared to normal values of our centre
(997 ± 27 ms, range: 943–1051 ms), (Fig. 1-Supplemental
Material). Infarct T1, paralleling the behavior of T2,
increased with the increase of TRevasc-CMR tertiles,. Post-hoc
analysis revealed that T1 values increased from Tertile-1 to
Tertile-2 without further increase from Tertile-2 to
Tertile-3. By dichotomizing patients based on the presence
or absence of IMH, only those without IMH increased
infarct T1 value with the increase of TRevasc-CMR tertiles,
mirroring the results of T2 (Fig. 2-Supplemental Material).
When patients were divided according to pre-PPCI residual
blood flow, both subgroups showed significant increase of
T1 value in the infarct region with the increase of TRe-
vasc-CMR tertiles (Fig. 3-Supplemental Material). We calcu-
lated ECV of the infarct and remote regions in patients
without MVO (n = 68), given that state steady of
gadolinium-based contrast agent cannot be reached
between MVO (LGE-negative) and infarct (LGE-positive).
Fig. 1 Study Protocol
Table 1 Tertiles of the time elapsed from revascularization to CMR exam
Tertile Number of patients Time
(hour)
Median (25-75th percentiles), hours Median (25-75th percentiles), days Min / Max
(hours)
Tertile-1 54 ≤43.2 23.4 (20.3–33.5) 1.0 (0.8–1.4) 6.2 / 42.5
Tertile-2 55 > 43.2 but ≤93.1 65.7 (50.1–79.1) 2.7 (2.1–3.3) 43.5 / 93.0
Tertile-3 54 > 93.1 127.1 (108.9–187.8) 5.3 (4.5–7.8) 93.3 / 332.4
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Infarct and remote ECV values were comparable through-
out TRevasc-CMR tertiles (Fig. 4-Supplemental Material).
Discussion
In a cohort of consecutive unselected STEMI patients
treated by PPCI and undergoing comprehensive CMR
during the index hospitalization, we found that
T2-maps-based AAR quantification was independent of
the timing of CMR after revascularization (TRevasc-CMR).
Although T2 values of the infarct region increased with in-
creasing time interval between revascularization and CMR,
T2 values of the infarct largely exceeded those of the
Table 2 Baseline Characteristics
Characteristics Overall
(n = 163)
Tertile-1
(n = 54)
Tertile-2
(n = 55)
Tertile-3
(n = 54)
P-value
Age (years) 60 ± 13 60 ± 14 57 ± 14 63 ± 11 0.054
Male Gender n, (%) 120 (74) 40 (74) 39 (71) 41 (76) 0.835
FH for CAD n, (%) 19 (12) 9 (17) 6 (11) 4 (7) 0.318
Diabetes n, (%) 24 (15) 7 (13) 5 (9) 12 (22) 0.139
Hypertension n (%) 90 (55) 27 (50) 28 (51) 35 (65) 0.219
Hypercholesterolemia n, (%) 92 (53) 30 (56) 33 (60) 29 (54) 0.658
Active Smoking n, (%) 66 (40) 20 (37) 26 (47) 20 (37) 0.453
Prodromal Angina n. (%) 55 (34) 19 (35) 20 (36) 16 (30) 0.731
Time-to-PPCI (min) 195 (128–270) 209 (129–270) 173 (125–208) 197 (149–303) 0.111
Systolic blood pressure (mmHg) 119 ± 21 124 ± 22 120 ± 21 114 ± 20 0.061
Diastolic blood pressure (mmHg) 70 ± 14 71 ± 15 72 ± 14 68 ± 13 0.368
Heart Rate (bpm) 75 ± 16 74 ± 14 73 ± 15 78 ± 19 0.165
RPP before PPCI (mmHg∙bpm) 9032 ± 2713 9296 ± 2780 8779 ± 2547 9027 ± 2831 0.613
Infarct related artery n, (%) 0.537
LAD 74 (45) 28 (52) 23 (42) 23 (43)
RCA 62 (38) 17 (31) 25 (46) 20 (37)
LCX 27 (17) 9 (17) 7 (13) 11 (20)
Anterior Infarction n, (%) 74 (45) 28 (52) 23 (41) 23 (43) 0.506
Non-IRA critical stenosis n, (%) 0.865
0 79 (49) 28 (52) 28 (51) 23 (43)
1 51 (31) 15 (25) 17 (31) 19 (35)
2 33 (20) 11 (20) 10 (18) 12 (22)
TIMI flow-grade pre-PPCI n, (%) 0.237
0,1 121 (74) 40(74) 37 (67) 44 (82)
2,3 42 (26) 14 (26) 18 (33) 10 (19)
TIMI flow-grade post-PPCI n, (%) 0.444
0,1 2 (1) 0(0) 1 (2) 1 (2)
2,3 161 (99) 54 (100) 54 (98) 53 (98)
Rentrop flow-grade n, (%) 0.152
0,1 152 (93) 53 (98) 50 (91) 49 (91)
2,3 11 (7) 1 (2) 5 (9) 5 (9)
Medication at discharge
ACEi or ARBs n, (%) 160 (98) 53 (98) 53 (96) 54 (100) 0.369
Beta-blockers n, (%) 126 (77) 39 (72) 44 (80) 43 (80) 0.552
Statins n, (%) 154 (95) 51 (94) 54 (98) 53 (98) 0.458
Diuretics n, (%) 13 (8) 2 (4) 4 (7) 7 (13) 0.197
ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CAD coronary artery disease, FH familial history, IRA infarct-related artery, LAD left
anterior descending artery, LCX:left circumflex, PPCI primary percutaneous coronary intervention, RCA right coronary artery, RPP rate-pressure product, TIMI
Thrombolysis In Myocardial Infarction
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remote myocardium yielding constant AAR despite the
increase of TRevasc-CMR. These findings were confirmed
irrespective of presence or absence of IMH and of
pre-PPCI residual flow in the myocardium at risk. Finally,
LGE-dependent metrics, including infarct size and MVO
occurrence and its extent, were independent of the timing
of CMR after revascularization.
Recent reports generated intense discussion on the
dynamic changes of CMR-derived measures of ischemic
damage in early post-STEMI phase with particular
emphasis on myocardial edema. In elegant experimental
studies [6, 7, 9], Fernàndez-Jiménez et al. showed that
edema features a bimodal pattern after reperfusion. An
initial wave of edema appears abruptly and very early
(≤3 h) to be attenuated at 24 h and followed by a second
edema wave peaking at 4 to 7 days. The same group
described this bimodal pattern in a selected cohort of 16
reperfused STEMI patients undergoing serial CMR (8). In
patients, the authors found that T2 values within the
ischemic region, as measured by T2-mapping, varied
consistently throughout the post-reperfusion phase paral-
leling the experimental results. Accordingly, AAR, as
quantified by T2-weighted short-TI (T2w-STIR), changed
substantially with the timing of CMR being significantly
lower at 24 h than at hyper-acute (≤3 h) or at 4 and 7 days
after reperfusion. In line with these findings, we observed
that T2 of the infarct increased with the increase of timing
of CMR after revascularization, with a steep augmentation
between Tertile-1 (median: 1.0 day) and Tertile-2 (median:
2.7 days) without further change between Tertile-2 and
Tertile-3 (median: 5.3 days). However differently from the
above study, we found that T2-map-derived AAR did not
vary with the timing of CMR after PPCI. This discrepancy
can be ascribed to the differences in study populations
and, most importantly, to the different techniques utilized
for AAR quantification. While Fernàndez-Jiménez’s et al.
utilized T2w-STIR, we used T2-mapping, which allows
more robust, precise and reproducible estimation of
infarct-related edema as compared to T2w-STIR [14, 15].
Different from T2w-STIR imaging, T2-mapping consents
to measure T2 lengthening of the ischemic tissue due to
increased water content, rendering this techniques par-
ticular sensitive to subtle changes in T2 relaxation times
[14, 17, 19]. Differently, T2-weightening relies on relative
signal intensity differences between ischemic and remote
myocardium, which are influenced by several factors in
addition to edema per se, such as specific T2-weightening
parameters, motion-related signal loss in the lateral wall
or selection of window/leveling to display images [15].
Accordingly, slight differences in T2 relaxation times
between ischemic and remote myocardium, such as those
reported in the experimental and clinical studies by
Fernàndez-Jiménez et al. [6–9] at 24-h after reperfusion,
might have been overlooked by T2w-STIR leading to
underestimation of AAR. In our study, T2 values of infarct
myocardium exceeded largely those of remote region irre-
spective of the time interval between revascularization
and CMR, the presence or absence of IMH, and pre-PPCI
Fig. 2 Box-plots of area-at risk, infarct size and myocardial salvage in the tertiles of Trevasc-CMR
Fig. 3 Error Bars showing the mean and 95% confidence intervals of
T2 values in infarct and remote regions across tertiles of Trevasc-CMR.
Error bar of healthy controls is reported as reference. (Bonferroni’s
post-hoc analysis: *P < 0.001; † P < 0.05)
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residual blood flow in the myocardium at risk. Accord-
ingly, we were able to quantify AAR on T2-maps using a
semi-automatic threshold-based algorithm in the overall
population and specific subgroups [17]. Moreover, the
pattern of T1 values in infarct and remote myocardium
paralleled closely that of T2, corroborating our study
results. Experimentally T1 relaxation time increases in
parallel with increasing myocardial water content, and
prolonged T1 has been reported in myocardium at risk in
STEMI patients [20, 21].
In summary, our data confirm the dynamic course of T2
in ischemic and remote myocardium as reported by others
[6–9]. However, these changes do not translate into
systematic variation of T2-mapping-based AAR quantifica-
tion, given the high sensitivity of this technique in captur-
ing subtle difference in T2 relaxation time between
ischemic and remote myocardium [14, 17].
In Tertile-1, we found that patients with residual blood
flow within AAR had lower infarct T2 values as
compared to those without. Leftover blood flow in the
territory at risk via either the infarct-related artery or
collaterals is effective in protecting the myocardium
from ongoing necrosis [22, 23]. Accordingly, recent
evidences suggested that the severity of edema, as quan-
tified by the lengthening of infarct T2 values, may be
influenced by infarct-limiting interventions [9, 24]. Thus,
cardioprotective strategies may reduce infarct T2 values,
and further dedicated studies are need to specifically
tackle this controversial aspect.
We also found that IMH influenced the pattern of
T2 within infarct so that patients with IMH had a
constant augmentation of T2 relaxation time after
reperfusion. Moreover, Tertile-1 patients with IMH
tended to have higher infarct T2 values than patients
Fig. 4 Error Bars showing the mean and 95% confidence intervals of T2 values in infarct and remote regions across tertiles of Trevasc-CMR in
patients with and without intramyocardial hemorrage (IMH). Error bar of healthy controls is reported as reference. (Bonferroni’s post-hoc analysis:
*P < 0.001; † P < 0.05)
Fig. 5 Error bars showing the mean and 95% confidence intervals of T2 values in infarct and remote regions across tertiles of Trevasc-CMR in
patients with and without residual pre-PPCI blood flow in the myocardium at risk. (Bonferroni’s post-hoc analysis: *P < 0.001; † P < 0.05)
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without IMH (P = 0.082). This result is in line with
experimental data reporting that after reperfusion the
increase of T2 values and water content in the infarct
region were associated with the severity of IMH [6–
9]. Overall the evidence converges in supporting the
concept that IMH is not necessarily associated with a
decrease of infarct T2 values, likely because T2 relax-
ation time represents the equipoise between the de-
structive paramagnetic effects of deoxyhemoglobin
(T2 decline) and the increase of tissue water content
(T2 raise), [6–9].
Finally, we observed that LGE-based estimate of infarct
size was independent of the timing of CMR after reperfu-
sion. This finding diverges from some previous clinical
studies, which reported a time dependency of LGE extent
prompting an overestimation of infarct size when CMR
was performed early after reperfusion [9–12]. However,
most of these studies included a small number of patients,
and the first CMR was performed at 24 h and then re-
peated 1 week or later not allowing to adequately tracking
infarct healing. In contradistinction, we divided the study
cohort according to the timing of CMR after reperfusion.
The tertiles thus obtained included more than 50 subjects
for each, and they were evenly balanced with respect to
clinical factors influencing I/R damage [13]. This allowed
superseding some of the previous study limitations and to
investigate how LGE-derived infarct size was influenced by
the timing of CMR throughout a broad interval spanning
from 6 h to 14 days after reperfusion. Furthermore, we
measured ECV of the infarct region in patients without
Table 3 CMR Characteristics
Characteristics Overall
(n = 163)
Tertile-1
(n = 54)
Tertile-2
(n = 55)
Tertile-3
(n = 54)
P-Value
For trend
Infarct-related Measures
AAR (g) 23 ± 12 20 ± 12 23 ± 11 25 ± 13 0.113
AAR (% LV) 18 ± 8 17 ± 9 19 ± 9 18 ± 8 0.385
IMH n, (%) 46 (28) 12 (22) 17 (31) 17 (31) 0.487
IMH extent (g) 2.8 (1.6–5.4) 2.8 (1.5–9.2) 3.0 (2.1–4.8)8 2.4 (1.1–5.4) 0.794
IMH extent (% of LV) 2.0 (1.0–4.1) 2.7 (1.0–7.2) 2.4 (1.3–3.9) 1.9 (0.8–3.9)1 0.681
Infarct size (g) 16 ± 13 15 ± 12 16 ± 12 19 ± 14 0.271
Infarct size (% of LV) 13 ± 9 12 ± 9 12 ± 9 14 ± 9 0.646
MVO n, (%) 73 (45) 23 (43) 25 (46) 25 (46) 0.921
MVO extent (g) 4.0 (2.3–7.9) 3.0 (2.0–4.2) 5.6 (3.0–7.8) 5.0 (2.3–11.4) 0.294
MVO extent
(% of LV)
3.8 (1.8–6.9) 2.5 (1.5–4.5) 4.4 (2.0–6.9) 3.8 (1.9–8.0) 0.426
MSI (%) 31 (7–55) 24(8–48) 36 (8–58) 26 (1–51) 0.258
LV functional Parameters
LV-EDVi (ml/m2) 75 ± 19 71 ± 17 75 ± 18 80 ± 21 0.042
LV-ESVi (ml/m2) 35 ± 19 33 ± 13 34 ± 18 40 ± 22 0.068
LV-EF (%) 50 ± 12 51 ± 11 52 ± 11 48 ± 15 0.198
LV-Mi (g/m2) 66 ± 15 63 ± 15 67 ± 15 69 ± 15 0.129
RelaxationTimes
T2-mapping
T2 infarct (ms) 62.8 ± 6.4 60.0 ± 4.9†• 63.5 ± 5.6• 64.8 ± 7.5† < 0.001
T2 remote (ms) 45.5 ± 3.0 44.3 ± 2.8•* 46.1 ± 2.8• 46.1 ± 3.0* 0.001
T2 infarct core (ms) 47.0
(44.9–50.0)
47.5
(46.0–49.7)
45.8
(42.6–48.5)
48.0
(45.8–50.6)
0.071
T1-mapping*
T1 infarct (ms)* 1220 ± 81 1172 ± 63†• 1235 ± 78• 1248 ± 82† < 0.001
T1 remote (ms)* 1019 ± 59 1004 ± 37 1019 ± 54 1034 ± 76 0.076
ECV infarct (%)** 46.7 (41.5–52.0) 49.0 (41.6–53.1) 45.6 (41.7–52.9) 45.9 (40.1–49.5) 0.470
ECV remote (%)** 24.5 (22.1–27.1) 25.2 (22.0–27.0) 23.9 (22.3–25.7) 24.6 (22.0–28.3) 0.916
* n = 124; **n = 68. Bonferroni’s post-hoc analysis: •,* P < 0.05; † P < 0.001. AAR area at risk, ECV extracellular volume, EDVi end-diastolic volume index, EF ejection-
fraction, ESVi end-systolic volume index, IMH intramyocardial hemorrhage, LV left ventricular, Mi mass index, MVO microvascular obstruction, MSI myocardial
salvage index
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MVO, and this parameter remained stable across Tre-
vasc-CMR tertiles, providing a mechanistic insight about the
independency of LGE-derived infarct size from the timing
of CMR.
This study has several limitations. Firstly, it was
conducted in a tertiary referral center for PPCI and
CMR. Accordingly, we cannot exclude a referral bias.
Trevasc-CMR tertiles showed an even distribution of clin-
ical and hemodynamic factors influencing I/R damage
[11]. However, our study design cannot completely
remove bias in allocating subjects to the 3 tertiles.
Ideally, this limitation can be overcome by repeating
CMR at fixed time points in large cohort of patients.
However, this type of study entails complex protocols
arising also ethical concerns due to repeated administra-
tion of gadolinium-based contrast agent for IS. To the
best of our knowledge the largest study serially repeating
contrast-enhanced CMR in the early post-STEMI
included only 30 patients [5]. We did not use T2*-map-
ping for IMH identification and quantification to obviate
to off-resonance artifacts which are particularly cumber-
some at interface between myocardium and lung [25].
Conclusion
In this study including consecutive unselected reperfused
STEMI patients, CMR-derived parameters of I/R damage
were not influenced by the timing of CMR after reperfu-
sion. Although we acknowledge dynamic changes of T2
relaxation time of the infarct and the remote myocardium
after revascularization, however these variations did not
influence T2-mapping-derived AAR or LGE-based infarct
size. Accordingly, CMR remains a valid non-invasive im-
aging modality for characterizing and quantifying the di-
verse components of I/R damage in STEMI patients
during the early post-infarction phase.
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